IL-4 signalling is associated with COPD pathogenesis, where IL-4 effects of mucus hypersecretion [53], mucus gland hyperplasia, smooth muscle cell hypertrophy, and hyperplasia do occur [54]. Here, IL4 is linked to chronic obstructive pulmonary disease.